Interaction of eNOS polymorphism with MTHFR variants increase the risk of diabetic nephropathy and its progression in type 2 diabetes mellitus patients

Molecular and Cellular Biochemistry

Volumn 353, Issue 1-2, 2011, Pages 23-34

  Jafari, Yazdan ^a,b   Rahimi, Zohreh ^a,b   Vaisi Raygani, Asad ^b   Rezaei, Mansour ^b  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

eNOS G894T; Macroalbuminuria; Microalbuminuria; MTHFR C677T MTHFR A1298C; Type 2 diabetes mellitus

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ADULT; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DISEASE COURSE; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MOLECULAR INTERACTION; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AGED; ALBUMINURIA; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; EPISTASIS, GENETIC; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; RISK FACTORS;

EID: 79959262096     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-0770-0     Document Type: Article

References (33)

1. Felehgari V, Rahimi Z, Mozafari H, Vaisi-Raygani A (2011) ACE gene polymorphism and serum ACE activity in Iranians type II diabetic patients with macroalbuminuria. Mol Cell Biochem 346:23-30
2. Shin Shin Y, Baek SH, Chang KY et al (2004) Relations between eNOS Glu298Asp polymorphism and progression of diabetic nephropathy. Diabetes Res Clin Pract 65:257-265 (Pubitemid 39141182)
3. Ahluwalia TS, Ahuja M, Rai TS et al (2008) Endothelial nitric oxide synthase gene haplotypes and diabetic nephropathy among Asian Indians. Mol Cell Biochem 314:9-17
4. Zintzaras E, Papathanasiou AA, Stefanidis I (2009) Endothelial nitric oxide synthase gene polymorphisms and diabetic nephropathy: A HuGE review and meta-analysis. Genet Med 11:695-706
5. Zanchi A, Moczulski DK, Hanna LS et al (2000) Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int 57:405-413 (Pubitemid 30430632)
6. Ezzidi I, Mtiraoui N, Mohamed MB et al (2008) Association of endothelial nitric oxide synthase Glu298Asp, 4b/a, and 786T-C gene variants with diabetic nephropathy. J Diabetes Complications 22:331-338
7. Noiri E, Satoh H, Taguchi J et al (2002) Association of eNOS Glu298Asp polymorphism with end-stage renal disease. Hypertension 40:535-540
8. Thaha M, Pranawa Yogiantoro M et al (2008) Association of endothelial nitric oxide synthase Glu298Asp polymorphism with end-stage renal disease. Clin Nephrol 70:144-154
9. Nagase S, Suzuki H, Wang Y et al (2003) Association of ecNOS gene polymorphisms with end stage renal diseases. Mol Cell Biochem 244:113-118 (Pubitemid 36411061)
10. Azimi-Nezhad M, Ghayour-Mobarhan M, Parizadeh MR et al (2008) Prevalence of type 2 diabetes mellitus in Iran and its relationship with gender, urbanization, education, marital status and occupation. Singapore Med J 49:571-576
11. Rahimi M, Hasanvand A, Rahimi Z et al (2010) Synergistic effects of the MTHFR C677T and A1298C polymorphisms on the increased risk of micro- and macro-albuminuria and progression of diabetic nephropathy among Iranians with type 2 diabetes mellitus. Clin Biochem 43:1333-1339
12. Moczulski D, Fojcik H, Zukowska-Szczechowska E et al (2003) Effects of the C677T and A1298C polymorphisms of the MTHFR gene on the genetic predisposition for diabetic nephropathy. Nephrol Dial Transplant 18:1535-1540 (Pubitemid 36939625)
13. Kerkeni M, Addad F, Chauffert M et al (2006) Hyperhomocysteinemia, endothelial nitric oxide synthase polymorphism, and risk of coronary artery disease. Clin Chem 52:53-58 (Pubitemid 43032466)
14. WHO Study Group Report of a WHO consultation (1999) Part 1. Diagnosis and classification of diabetes mellitus. World Health Organization, Geneva
15. American Diabetes Association (2004) Nephropathy in diabetes. Diabetes Care 27:S79-S83
16. Old JM, Higgs DR (1983) Gene analysis. In: Weatherall DJ (ed) Methods in haematology, vol 6. The thalassemias. Livingstone, London, pp 74-101
17. Frosst P, Blom HJ, Milos R et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113
18. Mtiraoui N, Ezzidi I, Chaieb M et al (2007) MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients. Diabetes Res Clin Pract 75:99-106 (Pubitemid 44856026)
19. Miyamoto Y, Saito Y, Kajiyama N et al (1998) Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 32:3-8 (Pubitemid 28324117)
20. Vaisi-Raygani A, Rahimi Z, Tavilani H, Pourmotabbed T (2010) Butyrylcholinesterase K variant and the APOE-e4 allele work in synergy to increase the risk of coronary artery disease especially in diabetic patients. Mol Biol Rep 37:2083-2091
21. Zintzaras E, Lau J (2008) Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol 61:634-645 (Pubitemid 351766746)
22. Zintzaras E (2010) The generalized odds ratio as a measure of genetic risk effect in the analysis and meta-analysis of association studies. Stat Appl Genet Mol Biol 9:1-12
23. Odeberg J, Larsson CA, Rastam L, Lindblad U (2008) The Asp298 allele of endothelial nitric oxide synthase is a risk factor for myocardial infarction among patients with type 2 diabetes mellitus. BMC Cardiovasc Dis 8:36
24. Cam SF, Sekuri C, Tengiz I et al (2005) The G894T polymorphism on endothelial nitric oxide synthase gene is associated with premature coronary artery disease in a Turkish population. Thromb Res 116:287-292 (Pubitemid 40994910)
25. Nagib El-Kilany GE, Nayel E, Hazzaa S (2004) Nitric oxide synthase gene G298 allele is it a marker for microvascular angina in hypertensive patients? Cardiovasc Radiation Med 5:113-118
26. Colombo MG, Paradossi U, Andreassi MG et al (2003) Endothelial nitric oxide synthase gene polymorphisms and risk of coronary artery disease. Clin Chem 49:389-395 (Pubitemid 36250199)
27. Cai H, Wilcken DE, Wang XL (1999) The Glu 298 → Asp (894G → T) mutation at exon 7 of the endothelial nitric oxide synthase gene and coronary artery disease. J Mol Med 77:511-514 (Pubitemid 29372583)
28. Granath B, Taylor RR, van Bockxmeer FM, Mamotte CD (2001) Lack of evidence for association between endothelial nitric oxide synthase gene polymorphisms and coronary artery disease in the Australian Caucasian population. J Cardiovasc Risk 8:235-241 (Pubitemid 32803678)
29. Alp E, Menevse S, Tulmac M et al (2009) Lack of association between matrix metalloproteinase-9 and endothelial nitric oxide synthase gene polymorphisms and coronary artery disease in Turkish population. DNA Cell Biol 28:343-350
30. Mathew J, Narayanan P, Sundaram R et al (2008) Lack of association between Glu (298) Asp polymorphism of endothelial nitric oxide synthase (eNOS) gene and coronary artery disease in Tamilian population. Indian Heart J 60:223-227
31. Jaramillo PC, Lanas C, Lanas F, Salazar LA (2010) Polymorphisms of the NOS3 gene in Southern Chilean subjects with coronary artery disease and controls. Clin Chim Acta 411:258-262
32. Pereira AC, Sposito AC, Mota GF et al (2006) Endothelial nitric oxide synthase gene variant modulates the relationship between serum cholesterol levels and blood pressure in the general population: New evidence for a direct effect of lipids in arterial blood pressure. Atherosclerosis 184:193-200 (Pubitemid 41721088)
33. Zintzaras E, Uhlig K, Koukoulis GN et al (2007) Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy: a meta-analysis. J Hum Genet 52:881-890 (Pubitemid 350112482)